Resolving TYK2 locus genotype-to-phenotype differences reveals an immune signaling optimum that may be exploited therapeutically for treating autoimmune diseases.
Journal article
Science Translational Medicine
American Association for the Advancement of Science (AAAS)
02/11/2016
8